Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.Electrophoresis|June 23, 2005
Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditionsHong-Lei Huang, Taras Stasyk, Sandra Morandell, et al.Journal of Proteome Research|December 13, 2005
Poly(glycidyl methacrylate/divinylbenzene)-IDA-FeIII in phosphoproteomicsNurul H Aprilita, Christian W Huck, Rania Bakry, et al.Proteomics|March 11, 2010
QIKS--Quantitative identification of kinase substratesSandra Morandell, Karin Grosstessner-Hain, Elisabeth Roitinger, et al.Cancer Cell|November 26, 2015
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to ChemotherapyIan G Cannell, Karl A Merrick, Sandra Morandell, et al.Electrophoresis|March 22, 2006
Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assaysHong-Lei Huang, Taras Stasyk, Sandra Morandell, et al.Molecular Cell|October 12, 2010
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilizationH Christian Reinhardt, Pia Hasskamp, Ingolf Schmedding, et al.Nature Communications|August 19, 2020
Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpointsYi Wen Kong, Erik C Dreaden, Sandra Morandell, et al.Pageof 2